Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2022-02-17
Product name
HYCAMTIN INJECTABLE
Product Synonyms
HYCAMTIN INFUSION 1 MG/3 ML * HYCAMTIN INJECTION 1 MG/3 ML * HYCAMTIN INJECTION
1.2.2. Uses advised against
No other uses are advised
Icons in SDS
Company Information
company name
GlaxoSmithKline
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H300, H318, H340, H350, H360, H370
Hazard statements
Code
Statements
H300
Fatal if swallowed
Section 2
Physical hazards
Not classified.
Health hazards
Acute toxicity, oral Category 2 Serious eye damage/eye irritation Category 1 Germ cell mutagenicity Category 1 Carcinogenicity Category 1B Reproductive toxicity Category 1B Specific target organ toxicity following single Category 1 exposure
Environmental hazards
Not classified.
Signal word
Danger
Hazard statements
H300 Fatal if swallowed. H318 Causes serious eye damage. H340 May cause genetic defects. H350 May cause cancer. H360 May damage fertility or the unborn child. H370 Causes damage to organs.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P264 Wash thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves/protective clothing/eye protection/face protection.
Response
P301 + P310 IF SWALLOWED: Immediately call a POISON CENTRE/doctor/. P330 Rinse mouth. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 Immediately call a POISON CENTRE/doctor/.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/container to
Other hazards which do not result in classification
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
10 % of the mixture consists of component(s) of unknown acute dermal toxicity. National/local information Not available
